期刊文献+

腹膜透析相关肠源性腹膜炎38例的病原菌及药敏分析 被引量:1

An analysis on pathogenic bacteria and antibiotic sensitivity in 38 patients with peritoneal dialysis-related enterogenous peritonitis
原文传递
导出
摘要 目的分析38例(43例次)腹膜透析相关肠源性腹膜炎的病原菌及药敏。方法回顾性分析43例次肠源性腹膜炎患者的临床资料。结果病原菌为革兰阴性杆菌38例次,肠球菌6例次,两种菌混合感染5例次。最常见病原菌为革兰阴性杆菌,以大肠杆菌及肺炎克雷伯杆菌为主。革兰阴性杆菌对头孢哌酮舒巴坦、亚胺培南及美罗培南敏感。肠球菌对氨苄西林、万古霉素、替考拉宁和利奈唑胺敏感。因肠源性腹膜炎而致拔管1例、转血液透析1例、死亡4例,病原菌均为革兰阴性杆菌。肠球菌致病患者均得到完全缓解。结论腹膜透析患者肠源性腹膜炎最常见病原菌为革兰阴性菌,应选择敏感药物治疗。 Objective To analyze the pathogenic bacteria and antibiotic sensitivity in 38 patients(43 case-times)with peritoneal dialysis-related enterogenous peritonitis.Methods Data of in 38 patients with enterogenous peritonitis underwent peritoneal dialysis were retrospectively analyzed.Results Pathogenic bacteria were Gram-negative bacillus in 38 case-times,Enterococcus in 6 casetimes,and two kinds of bacteria mixed infection in 5case-times.Gram-negative bacilli were the most common pathogenic bacteria,which were mainly Escherichia coli and Klebsiella pneumoniae.Gramnegative bacilli were sensitive to cefoperazone sulbactam,imipenem and meropenem.Enterococcus was sensitive to ampicillin,vancomycin,teicoplanin and linezolid.Of six cases infected by Gram-negative bacillus,one case underwent catheter removal,one case received hemodialysis instead of peritoneal dialysis,and four cases died.The patients infected by Enterococcus were all completely remissioned after treatment.Conclusion Gram-negative bacilli are the most common pathogenic bacteria in the patients with peritoneal dialysis-related enterogenous peritonitis.The sensitive drugs should be selected in the treatment.
出处 《江苏医药》 CAS 2016年第7期781-783,共3页 Jiangsu Medical Journal
基金 苏州市科教兴卫青年科技项目(KJXW2012010)
关键词 腹膜透析 肠源性腹膜炎 病原菌 耐药性 Peritoneal dialysis Enterogenous peritonitis Pathogenic bacteria Drug resistance
  • 相关文献

参考文献8

二级参考文献29

  • 1李家泰,李耘,齐慧敏,代表中国细菌耐药监测研究组.2002—2003年中国革兰阴性细菌耐药性监测研究[J].中华检验医学杂志,2005,28(1):19-29. 被引量:296
  • 2Woodrow G,Turney JH ,Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival[J]. Perit Dial Int, 1997,17(4) : 360-364.
  • 3Keane WF, Bailie GR, Boeschoten E, et al.Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update[J]. Petit Dial Int, 2000,20(4) :396-411.
  • 4Kim DK, Yoo TH, Ryu DR, et al. Changes in causative organisms and their antimicrobial suscep tibilities in CAPD peritonitis: a single center's experience over one decade [J]. Petit Dial Int,2004,24(5) :424-432.
  • 5Sutherland R, Boon RJ, Griffin KE, et al. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for to picaluse[J]. Antimicrob Agents Chemother, 1985,27(4) : 495- 498.
  • 6Jonjic N,Peri G,Bernasconi S, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells[J]. J ExP Med, 1992,176(4) : 1165-1174.
  • 7Mahajan S,Tiwari SC,Kalra V,et al. Effect of local mupirotin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population[J]. Peritoneal Dialysis International, 2005,25 (5): 473-477.
  • 8Piraino B, Bernardini J, Florio T, et al. Staphylococcus aureus prophylaxis and trends in Gram-negative infections in peritoneal dialysis patients[J]. Perit Dial Int, 2003, 23 (5) :456- 459.
  • 9Annigeri R, Conly J, Vas S, et al. Emergence of mupiroeinresistant Staphylococcusaureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection[J]. Perit Dial Int, 2001,21 (6) : 554-559.
  • 10Mahaldar A, Weisz M, kathuria P. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis[J]. Advances in Peritoneal Dialysis, 2009,25 : 56-59.

共引文献16

同被引文献10

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部